["{\n\"step_by_step_thinking\": \"The relevant documents describe various forms of calcitonin gene-related peptide (CGRP) and the development of monoclonal antibodies that distinguish between alpha and beta forms. The CGRP antagonist activity of short C-terminal fragments, including CGRP(19-37), is also described. In one study, a CGRP antagonist missing the first 7 amino acids was used to prevent the effects of CGRP on T lymphocytes.\",\n\"answer_choice\": \"B: no\"\n}"]